Kosuke Kawaguchi

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 16, 2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Oct 08, 2024
Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.

Tomomi Nishimura, Ravi Velaga, Norikazu Masuda

|Jan 18, 2024
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.

Don Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda

|Dec 20, 2023
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.

Ayane Yamaguchi, Kosuke Kawaguchi, Kana Kawanishi

|Nov 22, 2023
Cellular senescence triggers intracellular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells.

Wei Li, Kosuke Kawaguchi, Sunao Tanaka

|Sep 29, 2022
Tumor immune microenvironment and systemic response in breast cancer.

Kosuke Kawaguchi, Yurina Maeshima, Masakazu Toi

Pageof 2

Frequent Collaborators

4 joint publications

Masakazu Toi

3 joint publications

Norikazu Masuda

2 joint publications

Takayuki Ueno

1 joint publications

Tetsuro Sasada